---
figid: PMC6156463__fgene-09-00394-g005
figlink: /pmc/articles/PMC6156463/figure/F5/
number: F5
caption: The distinct metabolic pathways in cancer cells and their connection to epigenetic
  modifications. Cancer cells have increased glucose and glutamine uptake, leading
  to accelerated glycolysis and biomass accumulation. PI3K/AKT is activated by growth
  factors to regulate glycolysis and acetyl-CoA generation. AKT induces the expression
  of GLUT1 to increase glucose uptake and phosphorylates HK1 and PFK to enhance aerobic
  glycolysis. AKT phosphorylates ACLY to increase acetyl-CoA production. Increased
  lactate dehydrogenase (LDH) activity and decreased pyruvate dehydrogenase (PDC)
  activity result in increased lactate export, attenuated TCA cycle and diversion
  of glycolysis to pentose phosphate pathway. ACLY, ACSS2 and PDC contribute to nuclear
  acetyl-CoA production and subsequent histone acetylation. Glycolysis is increased
  in cancer cells with NAD+ converted to NADH, leading to reduced NAD+/NADH ratio
  and downregulated activity of sirtuins, which results in histone hyperacetylation
  and dysregulation of gene expression. Serine and one-carbon metabolism is also accelerated
  in cancer cells to produce SAM, which is controlled by LKB-AMPK-mTOR pathway. α-KG
  is primarily produced by transamination of glutamate derived from glutamine in cancer
  cells. Mutations of IDH1/2 lead to accumulation of 2-HG, which increases histone
  methylation by inhibiting α-KG dependent enzymes. The potential targets for anti-cancer
  therapy were labeled in red color. ACSS2, acetyl-CoA synthetase short chain family
  member 2; AMPK, AMP-activated protein kinase; F-6-P, fructose-6-phosphate; FBP,
  fructose-1,6-biphosphate; GA3P, glyceraldehyde-3-phosphate; G-6-P, glucose-6-phosphate;
  Gln, glutamine; Glu, glutamate; HK1/2, hexokinase 1/2; LDHA, lactate dehydrogenase;
  MCT1, monocarboxylate transporter 1; MCT4, monocarboxylate transporter 4; MDH1,
  malate dehydrogenase 1; Mut IDH1/2, mutated isocitrate dehydrogenase 1 and 2; MTA,
  5′-methylthioadenosine; MTAP, MTA phosphorylase; NAM, nicotinamide; NAMPT, nicotinamide
  phosphoribosyltransferase; NMNATs, nicotinamide mononucleotide adenylyltransferases;
  PCK1, phosphoenolpyruvate carboxykinase 1; PDC, pyruvate dehydrogenase complex;
  PEP, phosphoenolpyruvate; PFK, phosphofructokinase; PI3K, phosphoinositide 3-kinase;
  PKM2, pyruvate kinase M2; PRMT5, arginine methyltransferase 5; PRPP, phosphoribosyl
  pyrophosphate; α-KG, α-ketoglutarate; 2-HG, 2-hydroxyglutarate; 3-P-G, 3-phosphoglycerate;
  ACLY, ATP-citrate lyase.
pmcid: PMC6156463
papertitle: Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications
  in Cancer.
reftext: Xilan Yu, et al. Front Genet. 2018;9:394.
pmc_ranked_result_index: '72357'
pathway_score: 0.960571
filename: fgene-09-00394-g005.jpg
figtitle: Distinct metabolic pathways in cancer cells and their connection to epigenetic
  modifications
year: '2018'
organisms:
- Homo sapiens
ndex: e2b6c9d7-dedd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6156463__fgene-09-00394-g005.html
  '@type': Dataset
  description: The distinct metabolic pathways in cancer cells and their connection
    to epigenetic modifications. Cancer cells have increased glucose and glutamine
    uptake, leading to accelerated glycolysis and biomass accumulation. PI3K/AKT is
    activated by growth factors to regulate glycolysis and acetyl-CoA generation.
    AKT induces the expression of GLUT1 to increase glucose uptake and phosphorylates
    HK1 and PFK to enhance aerobic glycolysis. AKT phosphorylates ACLY to increase
    acetyl-CoA production. Increased lactate dehydrogenase (LDH) activity and decreased
    pyruvate dehydrogenase (PDC) activity result in increased lactate export, attenuated
    TCA cycle and diversion of glycolysis to pentose phosphate pathway. ACLY, ACSS2
    and PDC contribute to nuclear acetyl-CoA production and subsequent histone acetylation.
    Glycolysis is increased in cancer cells with NAD+ converted to NADH, leading to
    reduced NAD+/NADH ratio and downregulated activity of sirtuins, which results
    in histone hyperacetylation and dysregulation of gene expression. Serine and one-carbon
    metabolism is also accelerated in cancer cells to produce SAM, which is controlled
    by LKB-AMPK-mTOR pathway. α-KG is primarily produced by transamination of glutamate
    derived from glutamine in cancer cells. Mutations of IDH1/2 lead to accumulation
    of 2-HG, which increases histone methylation by inhibiting α-KG dependent enzymes.
    The potential targets for anti-cancer therapy were labeled in red color. ACSS2,
    acetyl-CoA synthetase short chain family member 2; AMPK, AMP-activated protein
    kinase; F-6-P, fructose-6-phosphate; FBP, fructose-1,6-biphosphate; GA3P, glyceraldehyde-3-phosphate;
    G-6-P, glucose-6-phosphate; Gln, glutamine; Glu, glutamate; HK1/2, hexokinase
    1/2; LDHA, lactate dehydrogenase; MCT1, monocarboxylate transporter 1; MCT4, monocarboxylate
    transporter 4; MDH1, malate dehydrogenase 1; Mut IDH1/2, mutated isocitrate dehydrogenase
    1 and 2; MTA, 5′-methylthioadenosine; MTAP, MTA phosphorylase; NAM, nicotinamide;
    NAMPT, nicotinamide phosphoribosyltransferase; NMNATs, nicotinamide mononucleotide
    adenylyltransferases; PCK1, phosphoenolpyruvate carboxykinase 1; PDC, pyruvate
    dehydrogenase complex; PEP, phosphoenolpyruvate; PFK, phosphofructokinase; PI3K,
    phosphoinositide 3-kinase; PKM2, pyruvate kinase M2; PRMT5, arginine methyltransferase
    5; PRPP, phosphoribosyl pyrophosphate; α-KG, α-ketoglutarate; 2-HG, 2-hydroxyglutarate;
    3-P-G, 3-phosphoglycerate; ACLY, ATP-citrate lyase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADCY10
  - MFAP1
  - ADCY6
  - ADCY8
  - ACLY
  - ACSS2
  - PIK3CD
  - ADCY7
  - FBP1
  - ADCY5
  - MDH2
  - PIK3CG
  - PRKAA1
  - ADCY4
  - GLS
  - MTAP
  - MTOR
  - MUT
  - PKM
  - SLC2A1
  - HK1
  - PIK3R3
  - ADCY2
  - ADCY3
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - NAMPT
  - PCK1
  - HK2
  - PRKAG2
  - PRKAG3
  - ADCY1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - CD36
  - PDC
  - IDH1
  - POMC
  - PRMT5
  - STK11
  - MDH1
  - AKT2
  - IDH2
  - LDHA
  - ADCY9
  - AKT3
  - AKT1
  - PAEP
  - Glucose
  - NAMPT
  - AMP
  - ATP
  - Pentose Phosphate
  - NAD
  - Adenine
  - Nucleotides
  - Amino acids
  - Ga3P
  - NADH
  - Serine
  - Glu
  - Lactate
  - Pyruvate
  - Acetyl-CoA  Me  Me  Me  Pyruvate
  - Ac
  - Acetyl-CoA
  - Citrate
  - ACLAC Me Ac
  - TCA
  - Isocitrate
  - Acetate
  - Succinate
genes:
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: AMP/ATP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: ACLY
  symbol: ACLY
  source: hgnc_symbol
  hgnc_symbol: ACLY
  entrez: '47'
- word: ACSS2
  symbol: ACSS2
  source: hgnc_symbol
  hgnc_symbol: ACSS2
  entrez: '55902'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: FBP
  symbol: FBP
  source: hgnc_prev_symbol
  hgnc_symbol: FBP1
  entrez: '2203'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: MDH2
  symbol: MDH2
  source: hgnc_symbol
  hgnc_symbol: MDH2
  entrez: '4191'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: GLS
  symbol: GLS
  source: hgnc_symbol
  hgnc_symbol: GLS
  entrez: '2744'
- word: MTAP
  symbol: MTAP
  source: hgnc_symbol
  hgnc_symbol: MTAP
  entrez: '4507'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Mut
  symbol: MUT
  source: hgnc_symbol
  hgnc_symbol: MUT
  entrez: '4594'
- word: PKM2|
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: GLUT1
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: HK1/2
  symbol: HK1
  source: hgnc_symbol
  hgnc_symbol: HK1
  entrez: '3098'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: NAMPT,
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: PCK1|
  symbol: PCK1
  source: hgnc_symbol
  hgnc_symbol: PCK1
  entrez: '5105'
- word: HK1/2
  symbol: HK2
  source: hgnc_symbol
  hgnc_symbol: HK2
  entrez: '3099'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: FAT
  symbol: FAT
  source: hgnc_alias_symbol
  hgnc_symbol: CD36
  entrez: '948'
- word: PDC
  symbol: PDC
  source: hgnc_symbol
  hgnc_symbol: PDC
  entrez: '5132'
- word: IDH1/2
  symbol: IDH1
  source: hgnc_symbol
  hgnc_symbol: IDH1
  entrez: '3417'
- word: POC
  symbol: POC
  source: hgnc_alias_symbol
  hgnc_symbol: POMC
  entrez: '5443'
- word: PRMT5
  symbol: PRMT5
  source: hgnc_symbol
  hgnc_symbol: PRMT5
  entrez: '10419'
- word: LKB1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: MDH1
  symbol: MDH1
  source: hgnc_symbol
  hgnc_symbol: MDH1
  entrez: '4190'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IDH1/2
  symbol: IDH2
  source: hgnc_symbol
  hgnc_symbol: IDH2
  entrez: '3418'
- word: LDHA
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PEP
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: NAMPT
  source: MESH
  identifier: C085455
- word: AMP
  source: MESH
  identifier: D000249
- word: ATP
  source: MESH
  identifier: D000255
- word: Pentose Phosphate
  source: MESH
  identifier: D010429
- word: NAD
  source: MESH
  identifier: D009243
- word: Adenine
  source: MESH
  identifier: D000225
- word: Nucleotides
  source: MESH
  identifier: D009711
- word: Amino acids
  source: MESH
  identifier: D000596
- word: Ga3P
  source: MESH
  identifier: C043055
- word: NADH
  source: MESH
  identifier: D009243
- word: Serine
  source: MESH
  identifier: C047902
- word: Glu
  source: MESH
  identifier: C094686
- word: Lactate
  source: MESH
  identifier: D019344
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Acetyl-CoA  Me  Me  Me  Pyruvate
  source: MESH
  identifier: C526611
- word: Ac
  source: MESH
  identifier: D000186
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: Citrate
  source: MESH
  identifier: C102006
- word: ACLAC Me Ac
  source: MESH
  identifier: C061544
- word: TCA
  source: MESH
  identifier: C000589078
- word: Isocitrate
  source: MESH
  identifier: D007523
- word: Acetate
  source: MESH
  identifier: D000085
- word: Succinate
  source: MESH
  identifier: D013386
diseases: []
figid_alias: PMC6156463__F5
redirect_from: /figures/PMC6156463__F5
figtype: Figure
---
